Skip to main content

Table 2 LPD training data: Demographics and the top 5 treatment prescription (178,962 patients)

From: Artificial intelligence to differentiate asthma from COPD in medico-administrative databases

 

Asthma

COPD

Both

Other

Demographics characteristics

    

Number of patients

76,953

28,635

7,158

66,216

Mean age (SD):

44 (25)

67 (12)

63 (16)

51 (25)

% female

56

40

53

54

Top 5 classes of treatments (% of patients)

    

1

ICS/LABA: 68

ICS/LABA: 54

ICS/LABA: 76

ICS monotherapy: 54

2

ICS monotherapy: 39

LAMA: 47

LAMA: 47

ICS/LABA: 47

3

LTRA: 25

LABA/LAMA: 33

ICS monotherapy: 32

LTRA: 14

4

LABA: 7

LABA: 21

LTRA: 22

LAMA: 10

5

LAMA: 7

ICS monotherapy: 18

LABA/LAMA: 26

LABA: 7

  1. COPD chronic obstructive pulmonary disease, ICS inhaled corticosteroids, LABA long-acting beta-2 agonist, LAMA long-acting muscarinic antagonist, LPD longitudinal patient database, LTRA leukotriene receptor antagonist
  2. *ICS/LABA considered as a single drug including both product